Aurora Cannabis Inc [NASDAQ: ACB] traded at a low on Friday, posting a -0.15 loss after which it closed the day’ session at $6.70. The results of the trading session contributed to over 10032018 shares changing hands. Over the past one week, the price volatility
Aurora Cannabis Inc [NASDAQ: ACB] jumped around 1.14 points on Tuesday, while shares priced at $7.42 at the close of the session, up 18.15%. Compared to the average trading volume of 5.67M shares, ACB reached a trading volume of 9352862 in the most recent trading
Aurora Cannabis Inc [NASDAQ: ACB] stock went on a downward path that fall over -3.37% on Friday, amounting to a one-week price decrease of less than -0.45%. Over the last 12 months, ACB stock rose by 1.38%. The one-year Aurora Cannabis Inc stock forecast points
Aurora Cannabis Inc [NASDAQ: ACB] price plunged by -6.09 percent to reach at -$0.43. The company report on April 1, 2024 at 7:00 AM that Aurora Cannabis Commends Germany’s Landmark Legalization Achievement. NASDAQ | TSX: ACB. The Expected De-scheduling of Cannabis to Fuel Expansion of
Aurora Cannabis Inc [NASDAQ: ACB] closed the trading session at $5.01. The company report on April 1, 2024 at 7:00 AM that Aurora Cannabis Commends Germany’s Landmark Legalization Achievement. NASDAQ | TSX: ACB. The Expected De-scheduling of Cannabis to Fuel Expansion of the Medical Cannabis
Aurora Cannabis Inc [NASDAQ: ACB] slipped around -0.72 points on Monday, while shares priced at $4.14 at the close of the session, down -14.81%. The company report on March 20, 2024 at 7:15 AM that Aurora Cannabis Achieves Australia’s TGA GMP Certification, Setting Global Standard
Aurora Cannabis Inc [NASDAQ: ACB] closed the trading session at $4.86. The company report on March 20, 2024 at 7:15 AM that Aurora Cannabis Achieves Australia’s TGA GMP Certification, Setting Global Standard for Quality and Compliance. Milestone Achievement Signals Company’s Commitment to Solidifying its Leadership
Aurora Cannabis Inc [NASDAQ: ACB] price surged by 16.35 percent to reach at $0.52. The company report on March 4, 2024 at 9:30 AM that Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia.
Aurora Cannabis Inc [NASDAQ: ACB] closed the trading session at $0.40. The company report on February 8, 2024 at 7:00 AM that Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million.
Aurora Cannabis Inc [NASDAQ: ACB] stock went on an upward path that rose over 5.26% on Tuesday, amounting to a one-week price increase of more than 1.01%. The company report on January 31, 2024 at 7:00 AM that Aurora Cannabis Provides Business Update and Announces
© 2024, Powered by Smart TechOne
